VA
AZN icon

VestGen Advisors’s AstraZeneca AZN Stock Holding History

VestGen Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630K Sell
3,325
-365
-10% -$68.7K 0.02% 592
2026
Q1 		$681K Sell
3,690
-4,162
-53% -$803K 0.02% 569
2025
Q4 		$1.44M Buy
7,852
+5,924
+307% +$1.04M 0.06% 293
2025
Q3 		$296K Buy
+1,928
New +$292K 0.01% 598

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VestGen Advisors's AZN Position: Q2 2026 in Review

VestGen Advisors reduced its AstraZeneca (AZN) stake by 9.9% in Q2 2026, selling an estimated $68.7K and leaving 3,325 shares worth $630K. The position accounts for 0.02% of the portfolio, ranked #592.

VestGen Advisors first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.44M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • VestGen Advisors held 3,325 shares of AstraZeneca worth $630K as of Q2 2026.
  • VestGen Advisors sold 365 AstraZeneca shares in Q2 2026, an estimated $68.7K.
  • AstraZeneca made up 0.02% of VestGen Advisors's portfolio in Q2 2026, its #592 holding.
  • VestGen Advisors first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • VestGen Advisors's AstraZeneca position peaked at $1.44M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.